Breast Cancer EpiAxis Therapeutics Announces Positive Clinical Trial Data for its New Drug Program to Inhibit Metastatic Breast CancerBy adminJune 9, 20220 EpiAxis Therapeutics is based in Sydney, Australia. EpiAxis Therapeutics has announced a pioneering clinical study, showing that an epigenetic inhibitor…
